← Leaderboards
Theodore Scott Nowicki
University Of California Los Angeles
$1,557,062
Attributed
$1,557,062
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $829.5K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,557,062 · 2
By mechanism
K08$909,430 · 1
R37$647,632 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Margaret Goodell$39,279,889
- Dinesh S Rao$5,891,931
- Albert Lai$2,387,656
- Guido Erwin Michael Eibl$7,914,971
- Kathleen Miho Sakamoto$11,054,872
Others in their field
Other Emerging Leaders on “Phenotype”
- Leonard Freedman · Leidos Biomedical Research, Inc.$68,463,085
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$28,580,688
- Evan Z Macosko · Broad Institute, Inc.$28,218,682
- Badri N Vardarajan · University Of Miami School Of Medicine$23,982,327
Research focus
PhenotypeTransgenic OrganismsGene ExpressionIn VivoT-Cell ReceptorT-LymphocyteCytokineDesignImmunotherapyIncidenceResponders And Non-RespondersResponseCancer ImmunotherapyT Cell TherapyCancer TherapyCancer TypeCell TherapyCytometryCellular ImmunotherapyGene Expression ProfileImpairmentCellsRecurrent DiseaseTreatment Failure
Grant awards (6)
TNF-alpha-"armed" TCR vectors to enhance adoptive cell therapy for solid tumors$647,632
R37 · FY2025 · CA · contact PI
Functional epigenomics of transgenic cellular immunotherapies for cancer$181,886
K08 · FY2025 · CA · contact PI
Functional epigenomics of transgenic cellular immunotherapies for cancer$181,886
K08 · FY2024 · CA · contact PI
Functional epigenomics of transgenic cellular immunotherapies for cancer$181,886
K08 · FY2023 · CA · contact PI
Functional epigenomics of transgenic cellular immunotherapies for cancer$181,886
K08 · FY2022 · CA · contact PI
Functional epigenomics of transgenic cellular immunotherapies for cancer$181,886
K08 · FY2021 · CA · contact PI